Skip to the page

Data / Form D filings / Nephron Pharmaceuticals Corp

Nephron Pharmaceuticals Corp: Form D filing

Nephron Pharmaceuticals Corp, a business services company in Orlando, FL, filed a Form D with the SEC in 2014. The latest, on August 21, 2014, reports $75 million sold of a $75 million offering to 8 investors.

Find out what Nephron Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3855 ST. VALENTINE WAY, Orlando, FL, 32811
Phone
(800) 443-3414
Industry
Business Services
Entity type
Corporation
Incorporated in
Florida
Revenue range
Over $100,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1617435

The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Business Services: 760 rows, $38, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 21, 2014New notice$75,000,000$75,000,000$08Aug 7, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lou Wood KennedyExecutive Officer, Director
William P. KennedyDirector

Other business services companies in Florida that filed recently

Every Form D from the week of Aug 18, 2014 · All recent filings in Florida · All recent Business Services filings

Read from SEC EDGAR. Amount sold is what Nephron Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.